vs

Side-by-side financial comparison of Expeditors International (EXPD) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

Expeditors International is the larger business by last-quarter revenue ($2.9B vs $1.5B, roughly 1.9× BeOne Medicines Ltd.). Expeditors International runs the higher net margin — 7.0% vs 4.4%, a 2.6% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs -3.3%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $270.3M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 13.8%).

Expeditors International of Washington, Inc. is an American Fortune 500 service-based logistics company with headquarters in Bellevue, Washington. Expeditors generates highly optimized and customized supply chain solutions for clients with unified technology systems integrated through a global network of over 340+ locations in 100+ countries on six continents.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

EXPD vs ONC — Head-to-Head

Bigger by revenue
EXPD
EXPD
1.9× larger
EXPD
$2.9B
$1.5B
ONC
Growing faster (revenue YoY)
ONC
ONC
+36.2% gap
ONC
32.8%
-3.3%
EXPD
Higher net margin
EXPD
EXPD
2.6% more per $
EXPD
7.0%
4.4%
ONC
More free cash flow
ONC
ONC
$109.5M more FCF
ONC
$379.8M
$270.3M
EXPD
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
13.8%
EXPD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EXPD
EXPD
ONC
ONC
Revenue
$2.9B
$1.5B
Net Profit
$200.7M
$66.5M
Gross Margin
90.5%
Operating Margin
8.8%
12.4%
Net Margin
7.0%
4.4%
Revenue YoY
-3.3%
32.8%
Net Profit YoY
-14.9%
143.8%
EPS (diluted)
$1.50
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EXPD
EXPD
ONC
ONC
Q4 25
$2.9B
$1.5B
Q3 25
$2.9B
$1.4B
Q2 25
$2.7B
$1.3B
Q1 25
$2.7B
$1.1B
Q4 24
$3.0B
$1.1B
Q3 24
$3.0B
$1.0B
Q2 24
$2.4B
$929.2M
Q1 24
$2.2B
$751.7M
Net Profit
EXPD
EXPD
ONC
ONC
Q4 25
$200.7M
$66.5M
Q3 25
$222.3M
$124.8M
Q2 25
$183.6M
$94.3M
Q1 25
$203.8M
$1.3M
Q4 24
$235.9M
$-151.9M
Q3 24
$229.6M
$-121.3M
Q2 24
$175.5M
$-120.4M
Q1 24
$169.2M
$-251.2M
Gross Margin
EXPD
EXPD
ONC
ONC
Q4 25
90.5%
Q3 25
86.1%
Q2 25
87.5%
Q1 25
85.2%
Q4 24
85.8%
Q3 24
83.0%
Q2 24
85.1%
Q1 24
83.4%
Operating Margin
EXPD
EXPD
ONC
ONC
Q4 25
8.8%
12.4%
Q3 25
10.0%
11.5%
Q2 25
9.3%
6.7%
Q1 25
10.0%
1.0%
Q4 24
10.2%
-7.0%
Q3 24
10.1%
-12.0%
Q2 24
9.2%
-11.5%
Q1 24
9.7%
-34.8%
Net Margin
EXPD
EXPD
ONC
ONC
Q4 25
7.0%
4.4%
Q3 25
7.7%
8.8%
Q2 25
6.9%
7.2%
Q1 25
7.6%
0.1%
Q4 24
8.0%
-13.5%
Q3 24
7.7%
-12.1%
Q2 24
7.2%
-13.0%
Q1 24
7.7%
-33.4%
EPS (diluted)
EXPD
EXPD
ONC
ONC
Q4 25
$1.50
$0.05
Q3 25
$1.64
$0.08
Q2 25
$1.34
$0.06
Q1 25
$1.47
$0.00
Q4 24
$1.68
$-0.10
Q3 24
$1.63
$-0.09
Q2 24
$1.24
$-0.09
Q1 24
$1.17
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EXPD
EXPD
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$1.3B
$4.5B
Total DebtLower is stronger
$836.4M
Stockholders' EquityBook value
$2.4B
$4.4B
Total Assets
$4.9B
$8.2B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EXPD
EXPD
ONC
ONC
Q4 25
$1.3B
$4.5B
Q3 25
$1.2B
$4.0B
Q2 25
$1.2B
$2.8B
Q1 25
$1.3B
$2.5B
Q4 24
$1.1B
$2.6B
Q3 24
$1.3B
$2.7B
Q2 24
$1.3B
$2.6B
Q1 24
$1.4B
$2.8B
Total Debt
EXPD
EXPD
ONC
ONC
Q4 25
$836.4M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
EXPD
EXPD
ONC
ONC
Q4 25
$2.4B
$4.4B
Q3 25
$2.3B
$4.1B
Q2 25
$2.2B
$3.8B
Q1 25
$2.3B
$3.5B
Q4 24
$2.2B
$3.3B
Q3 24
$2.4B
$3.4B
Q2 24
$2.2B
$3.4B
Q1 24
$2.2B
$3.4B
Total Assets
EXPD
EXPD
ONC
ONC
Q4 25
$4.9B
$8.2B
Q3 25
$4.8B
$7.6B
Q2 25
$4.8B
$6.3B
Q1 25
$4.8B
$5.8B
Q4 24
$4.8B
$5.9B
Q3 24
$5.2B
$5.8B
Q2 24
$4.8B
$5.7B
Q1 24
$4.5B
$5.7B
Debt / Equity
EXPD
EXPD
ONC
ONC
Q4 25
0.19×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EXPD
EXPD
ONC
ONC
Operating Cash FlowLast quarter
$283.3M
$417.3M
Free Cash FlowOCF − Capex
$270.3M
$379.8M
FCF MarginFCF / Revenue
9.5%
25.4%
Capex IntensityCapex / Revenue
0.5%
2.5%
Cash ConversionOCF / Net Profit
1.41×
6.28×
TTM Free Cash FlowTrailing 4 quarters
$953.4M
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EXPD
EXPD
ONC
ONC
Q4 25
$283.3M
$417.3M
Q3 25
$201.4M
$402.6M
Q2 25
$179.2M
$263.6M
Q1 25
$342.6M
$44.1M
Q4 24
$249.7M
$75.2M
Q3 24
$90.0M
$188.4M
Q2 24
$126.8M
$-95.6M
Q1 24
$256.9M
$-308.6M
Free Cash Flow
EXPD
EXPD
ONC
ONC
Q4 25
$270.3M
$379.8M
Q3 25
$190.3M
$354.5M
Q2 25
$163.3M
$219.8M
Q1 25
$329.5M
$-12.3M
Q4 24
$239.7M
$-17.3M
Q3 24
$77.7M
$54.7M
Q2 24
$118.8M
$-205.5M
Q1 24
$246.7M
$-465.1M
FCF Margin
EXPD
EXPD
ONC
ONC
Q4 25
9.5%
25.4%
Q3 25
6.6%
25.1%
Q2 25
6.2%
16.7%
Q1 25
12.4%
-1.1%
Q4 24
8.1%
-1.5%
Q3 24
2.6%
5.5%
Q2 24
4.9%
-22.1%
Q1 24
11.2%
-61.9%
Capex Intensity
EXPD
EXPD
ONC
ONC
Q4 25
0.5%
2.5%
Q3 25
0.4%
3.4%
Q2 25
0.6%
3.3%
Q1 25
0.5%
5.0%
Q4 24
0.3%
8.2%
Q3 24
0.4%
13.3%
Q2 24
0.3%
11.8%
Q1 24
0.5%
20.8%
Cash Conversion
EXPD
EXPD
ONC
ONC
Q4 25
1.41×
6.28×
Q3 25
0.91×
3.22×
Q2 25
0.98×
2.79×
Q1 25
1.68×
34.71×
Q4 24
1.06×
Q3 24
0.39×
Q2 24
0.72×
Q1 24
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EXPD
EXPD

Customs Brokerage And Other Services$1.1B40%
Airfreight Services$1.1B39%
Ocean Freight And Ocean Services$611.4M21%

ONC
ONC

Segment breakdown not available.

Related Comparisons